Mestag Therapeutics
Linghong Huang has been working in the field since 2006, starting as a Research Assistant at the University of Sheffield. In 2013, they moved to UCB, where they held the role of Senior Scientist and then Principal Scientist. In 2022, they joined Mestag Therapeutics as a Principal Scientist.
Linghong Huang obtained a Bachelor of Science (BSc) in Biochemistry from Sun Yat-sen University between 1993 and 1997. Afterwards, they continued their education at The University of Sheffield, where they obtained a Doctor of Philosophy (PhD) in Biomedical Sciences between 2002 and 2006.
This person is not in any offices
Mestag Therapeutics
Mestag was founded in 2020 by leading investigators and SV Health Investors to develop new medicines for people affected by inflammatory disease and cancer.